pharmaphorum

AUGUST 7, 2020

The US government has selected a potential vaccine from Sanofi and GlaxoSmithKline for its Operation Warp Speed COVID-19 vaccine development initiative, committing up to $2.1 billion for an initial 100 million doses.

Nursing Homes 97

Nursing Homes Vaccines Immunization Hospitals 97

pharmaphorum

AUGUST 23, 2021

Pfizer and BioNTech’s COVID-19 vaccine was the first to get emergency use authorisation (EUA) from the FDA, and has also become the first to get full regulatory approval in the US. The US has fully vaccinated more than half its total population, but is facing problems with vaccine hesitancy that is slowing down the rollout.

FDA 52

FDA Vaccines Nursing Homes 52

STAT

AUGUST 17, 2023

But the sizable paydays highlight how every niche of health care — from Covid-19 vaccines and obscure technology to orthopedic implants and providing coverage to the nation’s poor — continued to supply its leaders with substantial sums of money even as more people struggled to afford food, housing, and, yes, health care.

Nursing Homes 98

Nursing Homes Prescription Filling Insurance Hospitals 98

Druggist

AUGUST 8, 2020

It is expected to be that demand for flu vaccination service will be high this year. Additionally, eligibility criteria will be extended, for example, phased-out eligibility for free flu vaccination of those aged 50-64. This post is a summary of essential information about flu season 2020 and flu vaccination 2020/2021.

Vaccines 98

Vaccines Community Pharmacies Immunization Nursing Homes 98

Druggist

AUGUST 8, 2020

It is expected to be that demand for flu vaccination service will be high this year. Additionally, eligibility criteria will be extended, for example, phased-out eligibility for free flu vaccination of those aged 50-64. This post is a summary of essential information about flu season 2020 and flu vaccination 2020/2021.

Health and Personal Care Stores 98

Health and Personal Care Stores Vaccines Community Pharmacies Immunization 98

The Infectious Pharmacist

AUGUST 20, 2021

The vaccines are still highly effective. Vaccinated people are still very unlikely to have severe disease from COVID-19. The vaccines are still effective against the variants, including the Delta variant. So people who were vaccinated with a Pfizer or Moderna vaccine will soon not be protected?

Vaccines 52

Vaccines Immunization Nursing Homes Hospitals 52

Digital Pharmacist

SEPTEMBER 20, 2023

Breakdown of Medicare Types and Coverage Below is a quick summary to help your eligible patients prepare: Medicare Part A: Hospital insurance that includes inpatient and overnight hospital care, skilled nursing facility services, nursing home care, hospice care, and home health services.

Independent Pharmacies 105

Independent Pharmacies Insurance Nursing Homes Immunization 105

Digital Pharmacist

OCTOBER 5, 2022

Below is a quick summary to help your eligible patients prepare: Medicare Part A: Hospital insurance that includes inpatient and overnight hospital care, skilled nursing facility services, nursing home care, hospice care, and home health services. Antipsychotic medications. Immunosuppressant drugs.

Independent Pharmacies 98

Independent Pharmacies Nursing Homes Insurance Hospitals 98

pharmaphorum

JANUARY 29, 2023

Think about recent technological breakthroughs such as mRNA vaccines and the potential for mRNA-based therapeutics, or the recent ramp up in vaccine production facilities – to name just a few examples. That’s what is relentlessly driving industry growth, as well as spurring innovation and efficiency.

Nursing Homes 88

Nursing Homes Hospitals Vaccines 88

pharmaphorum

AUGUST 3, 2020

While the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug as an alternative way to prevent viral transmission in high-risk locations. The post Lilly’s antibody for COVID-19 protection starts nursing home trial appeared first on.

Nursing Homes 57

Nursing Homes Long-Term Care Facilities Immunization Vaccines 57

The Checkup by Singlecare

JANUARY 4, 2023

Nursing home or long-term care patients. For example, people at risk can get a pneumococcal and influenza vaccine to prevent serious problems. . A history of past chest colds. Certain groups of people may be at a higher risk of severe chest cold symptoms than others, including: older adults over 65. Children younger than 2.

Nursing Homes 52

Nursing Homes Immunization Controlled Substances Vaccines 52

SingleCare

NOVEMBER 18, 2019

Organize a free vaccination clinic for the community, or a health workshop where you teach the value of medication adherence. Visit a nursing home or staff an event at an after-school program or local recreation center. Pick a day when you and your coworkers can get involved in the community together.

Health and Personal Care Stores 52

Health and Personal Care Stores Nursing Homes Packaging Hospitals 52

pharmaphorum

AUGUST 18, 2021

The Biden administration has said that it will offer a COVID-19 booster dose to any adult American who was fully vaccinated eight months ago, in light of rising cases of the delta variant and evidence of waning protection with the current jabs. US Surgeon General Vivek Murthy. “This plan was not made lightly. pic.twitter.com/8y7SU5MpHz.

Nursing Homes 90

Nursing Homes Vaccines FDA 90

pharmaphorum

JUNE 15, 2021

The delta variant of COVID-19 may be holding back the lifting of lockdown restrictions in the UK, but there is some good news – the AstraZeneca/Oxford University vaccine seems to offer a high level of protection against it. formerly known as the Indian variant), with no deaths recorded, according to AZ.

Nursing Homes 117

Nursing Homes Vaccines 117

pharmaphorum

DECEMBER 15, 2020

Hospitals in the US have started vaccinating their front-line staff against COVID-19, as deaths in the country crossed the 300,000 threshold with more than 200,000 new cases reported yesterday. It’s likely to be months before all eligible healthcare workers for the first wave receive vaccinations. First Vaccine Administered.

Vaccines 52

Vaccines Nursing Homes Hospitals FDA 52

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May. What incentivises a country to cover a vaccine?

Vaccines 52

Vaccines Nursing Homes Pharmaceutical Companies Pharmaceutical Companies 52